Minimally-invasive procedure for vertebrogenic back pain
Official title: Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Run by Boston Scientific Corporation · NCT06827262 · Data updated 2026-11-12
This study looks at how well the Intracept™ procedure works for people with chronic low-back pain caused by vertebrogenic issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Boston Scientific Corporation Industry-sponsored |
| Locations | 22 sites (Flagstaff, Arizona and 21 other locations) |
| Status | Recruiting |
| Started | March 26, 2025 |
| Main results expected | July 2034 |
| Study ends | July 2034 |
| Registry record updated | October 9, 2026 |
| Trial ID | NCT06827262 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients diagnosed with vertebrogenic pain who are scheduled for treatment with the Intracept™ system.
✕Probably not a fit
Patients who have contraindications as per the Instructions for Use of the Intracept™ system may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compiles real-world outcomes from patients treated with the Intracept™ Intraosseous Nerve Ablation System for vertebrogenic pain. It focuses on chronic low-back pain and aims to gather data on the effectiveness of this commercially approved treatment. By observing patients scheduled for this procedure, the study seeks to provide insights into its real-world application and outcomes.
Why it matters
Potential benefit: If successful, this could provide patients with a minimally invasive option for managing chronic low-back pain effectively.
How similar studies have gone: Other studies have shown promising results with similar minimally invasive approaches for chronic low-back pain, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Study candidate is scheduled to be treated with a commercially approved Intracept™ Intraosseous Nerve Ablation System per local Instructions for Use (IFU). * Signed a valid, IRB/EC-approved informed consent form. Exclusion Criteria: * Meets any contraindications per locally applicable Instructions for Use (IFU).
Where it's running
-
Flagstaff Bone & Joint
Flagstaff, Arizona, United States Recruiting -
Innovative Pain and Wellness
Phoenix, Arizona, United States Recruiting -
MarinHealth Spine Institute
Larkspur, California, United States Recruiting -
Stanford University Medical Center
Stanford, California, United States Recruiting -
The Spine Wellness Center in Westport
Westport, Connecticut, United States Recruiting -
Washington Hospital Center
Washington D.C., District of Columbia, United States Recruiting
Show 16 more locations
-
Orlando Regional Medical Center
Orlando, Florida, United States Recruiting -
Horizon Clinical Research, LLC
Jasper, Georgia, United States Recruiting -
Illinois Bone and Joint Institute
Barrington, Illinois, United States Recruiting -
Commonwealth Pain and Spine
Lexington, Kentucky, United States Recruiting -
Ochsner Clinic Foundation
New Orleans, Louisiana, United States Recruiting -
iSpine Clinics
Maple Grove, Minnesota, United States Recruiting -
CentraCare Health System
Saint Cloud, Minnesota, United States Recruiting -
New York Spine and Pain Specialists
Port Jefferson Station, New York, United States Recruiting -
Montefiore Medical Center
The Bronx, New York, United States Recruiting -
Novant Health Spine Specialists
Bermuda Run, North Carolina, United States Recruiting -
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States Recruiting -
Cy-Pain and Spine
Houston, Texas, United States Recruiting -
University of Utah Orthopaedic Center
Salt Lake City, Utah, United States Recruiting -
North Idaho Day Surgery, LLC
Post Falls, Idaho, United States Withdrawn -
University of Rochester
Rochester, New York, United States Active not recruiting -
Pacific Sports and Spine
Eugene, Oregon, United States Active not recruiting
Study contacts
- Study coordinator: Ann Yamano
- Email: BSNClinicalTrials@bsci.com
- Phone: 855-213-9890
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.